Ipamorelin mastery course
Unit 5 of 11

The CJC-1295 stack

Ipamorelin is widely described online as being paired with CJC-1295.

Why ipamorelin is almost always paired

Ipamorelin is widely described online as being paired with CJC-1295. The only trace of that practice in this course’s sources is an expert quoted in FDA’s compounding review calling the combination "trending", and no source tests the two compounds together. The idea behind the pairing does have a footing: in 1990, in normal men, a growth-hormone-releasing peptide and GHRH given together stimulated GH release synergistically, which the authors read as evidence that the two act independently.

Everything in this unit turns on how far that 1990 result carries. It used the prototype hexapeptide and native GHRH, not ipamorelin and not CJC-1295. This unit covers the pairing’s logic, the difference between the no-DAC and DAC versions of CJC-1295, why pulsatility is the argument people make, and how to read stack claims honestly.

Key terms

Two pathways, one pulse


How big is the synergy


No-DAC versus DAC


Why pulsatility is the argument


What the stack evidence supports


Reading stack claims critically